Weller, S., Reynaud, C. A. and Weill, J. C. (2005). Splenic marginal zone B cells in humans: where do they mutate their Ig receptor? Eur J Immunol 35, 2789-92. Willert, K. and Nusse, R. (1998). Beta-catenin: a key mediator of Wnt signaling. Curr Opin Genet Dev 8, 95-102. Williams, A. F. and Barc<strong>la</strong>y, A. N. (1988). The immunoglobulin superfamily--domains for cell surface recognition. Annu Rev Immunol 6, 381-405. Wilson, A., MacDonald, H. R. and Radtke, F. (2001). Notch 1-<strong>de</strong>ficient common lymphoid precursors adopt a B cell fate in the thymus. J Exp Med 194, 1003-12. Wortis, H. H. and Ber<strong>la</strong>nd, R. (2001). Cutting edge commentary: origins of B-1 cells. J Immunol 166, 2163-6. Yamamura, K., Kudo, A., Ebihara, T., Kamino, K., Araki, K., Kumahara, Y. and Watanabe, T. (1986). Cell-type-specific and regu<strong>la</strong>ted expression of a human gamma 1 heavychain immunoglobulin gene in transgenic mice. Proc Natl Acad Sci U S A 83, 2152-6. Yamanashi, Y., Fukui, Y., Wongsasant, B., Kinoshita, Y., Ichimori, Y., Toyoshima, K. and Yamamoto, T. (1992). Activation of Src-like protein-tyrosine kinase Lyn and its association with phosphatidylinositol 3-kinase upon B-cell antigen receptor-mediated signaling. Proc Natl Acad Sci U S A 89, 1118-22. Yamanashi, Y., Kakiuchi, T., Mizuguchi, J., Yamamoto, T. and Toyoshima, K. (1991). Association of B cell antigen receptor with protein tyrosine kinase Lyn. Science 251, 192-4. Yamane-Ohnuki, N., Kinoshita, S., Inoue-Urakubo, M., Kusunoki, M., Iida, S., Nakano, R., Wakitani, M., Niwa, R., Sakurada, M., Uchida, K. et al. (2004). Establishment of FUT8 knockout Chinese hamster ovary cells: an i<strong>de</strong>al host cell line for producing completely <strong>de</strong>fucosy<strong>la</strong>ted antibodies with enhanced antibody-<strong>de</strong>pen<strong>de</strong>nt cellu<strong>la</strong>r cytotoxicity. Biotechnol Bioeng 87, 614-22. Yamauchi, M., Noyes, C., Kuboki, Y. and Mechanic, G. L. (1982). Col<strong>la</strong>gen structural microheterogeneity and a possible role for glycosy<strong>la</strong>ted hydroxylysine in type I col<strong>la</strong>gen. Proc Natl Acad Sci U S A 79, 7684-8. Yancopoulos, G. D. and Alt, F. W. (1985). Developmentally controlled and tissuespecific expression of unrearranged VH gene segments. Cell 40, 271-81. Yancopoulos, G. D. and Alt, F. W. (1986). Regu<strong>la</strong>tion of the assembly and expression of variable-region genes. Annu Rev Immunol 4, 339-68. Yang, R. Y. and Liu, F. T. (2003). Galectins in cell growth and apoptosis. Cell Mol Life Sci 60, 267-76. Yoshino, T., Kondo, E., Cao, L., Takahashi, K., Hayashi, K., Nomura, S. and Akagi, T. (1994). Inverse expression of bcl-2 protein and Fas antigen in lymphob<strong>la</strong>sts in peripheral lymph no<strong>de</strong>s and activated peripheral blood T and B lymphocytes. Blood 83, 1856-61. Yu, K., Chedin, F., Hsieh, C. L., Wilson, T. E. and Lieber, M. R. (2003). R-loops at immunoglobulin c<strong>la</strong>ss switch regions in the chromosomes of stimu<strong>la</strong>ted B cells. Nat Immunol 4, 442-51. Yuan, D., Witte, P. L., Tan, J., Hawley, J. and Dang, T. (1996). Regu<strong>la</strong>tion of IgM and IgD heavy chain gene expression: effect of abrogation of intergenic transcriptional termination. J Immunol 157, 2073-81. Zachau, H. G. (1993). The immunoglobulin kappa locus-or-what has been learned from looking closely at one-tenth of a percent of the human genome. Gene 135, 167-73. Zarrin, A. A., Alt, F. W., Chaudhuri, J., Stokes, N., Kaushal, D., Du Pasquier, L. and Tian, M. (2004). An evolutionarily conserved target motif for immunoglobulin c<strong>la</strong>ss-switch recombination. Nat Immunol 5, 1275-81. 178
Zarrin, A. A., Tian, M., Wang, J., Borjeson, T. and Alt, F. W. (2005). Influence of switch region length on immunoglobulin c<strong>la</strong>ss switch recombination. Proc Natl Acad Sci U S A 102, 2466-70. Zhang, L., David, G. and Esko, J. D. (1995). Repetitive Ser-Gly sequences enhance heparan sulfate assembly in proteoglycans. J Biol Chem 270, 27127-35. Zhang, Z., Espinoza, C. R., Yu, Z., Stephan, R., He, T., Williams, G. S., Burrows, P. D., Hagman, J., Feeney, A. J. and Cooper, M. D. (2006). Transcription factor Pax5 (BSAP) transactivates the RAG-mediated V(H)-to-DJ(H) rearrangement of immunoglobulin genes. Nat Immunol 7, 616-24. Zhou, D., Chen, C., Jiang, S., Shen, Z., Chi, Z. and Gu, J. (1998). Expression of beta1,4-ga<strong>la</strong>ctosyltransferase in the <strong>de</strong>velopment of mouse brain. Biochim Biophys Acta 1425, 204-8. Zimmermann, P. and David, G. (1999). The syn<strong>de</strong>cans, tuners of transmembrane signaling. Faseb J 13 Suppl, S91-S100. 179
- Page 1:
UNIVERSITE DE LIMOGES Ecole doctora
- Page 4 and 5:
de m’avoir donnée le goût pour
- Page 6 and 7:
KO : « knock-out » : délétion d
- Page 8 and 9:
Figure 27 : Les trois types de N-gl
- Page 10 and 11:
5.2.2. Les galectines, les voies No
- Page 13 and 14:
Afin d’assurer la défense de l
- Page 15:
conduire les cellules B au long de
- Page 19 and 20:
Les immunoglobulines sont des hét
- Page 21 and 22:
antigènes et dans la transduction
- Page 23 and 24:
1.2.2 Le Locus Igλ Les gènes de c
- Page 25 and 26:
empêcher des recombinaisons illég
- Page 27 and 28:
de l’ADN est réalisée par les p
- Page 29 and 30:
Figure 8 : Les nucléotides N et P.
- Page 31 and 32:
séquences Ig (Goodhardt et al., 19
- Page 33 and 34:
B, le nombre de cellules exprimant
- Page 35 and 36:
Des promoteurs ont également été
- Page 37 and 38:
maturation : aux stades précoces,
- Page 39 and 40:
jusqu’à Cδ, ne supprime pas pou
- Page 41 and 42:
3.1 La phase indépendante des anti
- Page 43 and 44:
Novobrantseva et al., 1999) et que
- Page 45 and 46:
Figure 14 : Bilan des blocages part
- Page 47 and 48:
Dendritic Cells »). Elles devienne
- Page 49 and 50:
sécrétrices est controversée. De
- Page 51 and 52:
et al., 2000; Chumley et al., 2000;
- Page 53 and 54:
La commutation isotypique, permetta
- Page 55 and 56:
L’action des cytokines semble s
- Page 57 and 58:
l’hypermutation (Muramatsu et al.
- Page 59 and 60:
IV. L’activation des lymphocytes
- Page 61 and 62:
La translocation du BCR après pont
- Page 63 and 64:
protéines. La protéine ZAP-70 ét
- Page 65 and 66:
comme NF-κB (Krappmann et al., 200
- Page 67 and 68:
démontré que CD22 était continue
- Page 69 and 70:
Figure 24 : Comparaison des région
- Page 71 and 72:
Au cours du développement B, le pr
- Page 73 and 74:
membranaire s’avère possible exp
- Page 75 and 76:
IgM/IgD (Brink et al., 1992; Spanop
- Page 77 and 78:
V. « Glycannes et glycoconjugués
- Page 79 and 80:
Groupe d'enzymes Sialyltransférase
- Page 81 and 82:
L’édification d’une structure
- Page 83 and 84:
5.1.2. La O-glycosylation des prot
- Page 85 and 86:
• la O-glucosylation qui a lieu s
- Page 87 and 88:
Les protéoglycannes peuvent varier
- Page 89 and 90:
o L’Héparane Sulfate (HS) et l
- Page 91 and 92:
C’est le premier hexosamine greff
- Page 93 and 94:
égion constante. L’analyse des d
- Page 95 and 96:
pathologies pour lesquelles l’ars
- Page 97 and 98:
intégrines VLA-4, VLA-5 et α4β7,
- Page 99 and 100:
thymocytes double négatifs CD4- CD
- Page 101 and 102:
délétion conditionnelle des gène
- Page 103 and 104:
Dans la MEC, les protéoglycannes f
- Page 105 and 106:
endothéliale, de façon à permett
- Page 107 and 108:
Résultats - Discussion 107
- Page 109 and 110:
Première partie : les BCR modifié
- Page 111 and 112:
Article 1 “Premature expression o
- Page 113 and 114:
Article 2 “B cells carying an IgE
- Page 115 and 116:
Demande de dépôt de brevet Etabli
- Page 117 and 118:
mécanismes relèvent les différen
- Page 119 and 120:
Etablissement et caractérisation d
- Page 121 and 122:
AUSUBEL, 2000, Wiley and son Inc, L
- Page 123 and 124:
4) Dosage du taux des IgG1 sérique
- Page 125 and 126:
- distribution d’un antisérum an
- Page 127 and 128: périphériques expriment pour envi
- Page 129 and 130: C. CONCLUSION Ce travail a reposé
- Page 131 and 132: Deuxième partie : les glycosaminog
- Page 133 and 134: Article 3 “Modulation of glycotra
- Page 135 and 136: Perspectives 135
- Page 137 and 138: L’état des réflexions sur les i
- Page 139 and 140: équipes de Tsubata et Goodnow avai
- Page 141 and 142: L’ouverture d’un nouveau champ
- Page 143 and 144: « Lymphomagenèse » dirigé par l
- Page 145 and 146: Annexes 145
- Page 147 and 148: Article 4 “RNA surveillance down-
- Page 149 and 150: Article 5 “Light chain inclusion
- Page 151 and 152: Références Bibliographiques 151
- Page 153 and 154: Abney, E. R., Cooper, M. D., Kearne
- Page 155 and 156: Brink, R., Goodnow, C. C., Crosbie,
- Page 157 and 158: Cogne, M., Lansford, R., Bottaro, A
- Page 159 and 160: Franke, T. F., Kaplan, D. R., Cantl
- Page 161 and 162: Hauke, G., Epplen, J. T., Chluba, J
- Page 163 and 164: Kao, Y. H., Lee, G. F., Wang, Y., S
- Page 165 and 166: Lieberson, R., Giannini, S. L., Bir
- Page 167 and 168: Meek, K. D., Hasemann, C. A. and Ca
- Page 169 and 170: Oberdoerffer, P., Novobrantseva, T.
- Page 171 and 172: Poellinger, L., Yoza, B. K. and Roe
- Page 173 and 174: Sato, M., Adachi, T. and Tsubata, T
- Page 175 and 176: Functional immunoglobulin transgene
- Page 177: Vilen, B. J., Famiglietti, S. J., C